Forefront Analytics, LLC Jasper Therapeutics, Inc. Transaction History

Forefront Analytics, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$0.68 - $1.54 $28,169 - $63,794	41,425 Added 59.72%	110,792 $77,000
Q2 2023 Aug 11, 2023	BUY	$1.19 - $1.79 $46,501 - $69,947	39,077 Added 129.01%	69,367 $95,000
Q1 2023 May 11, 2023	SELL	$1.48 - $2.74 $123,890 - $229,365	-83,710 Reduced 73.43%	30,290 $54,000
Q4 2022 Feb 13, 2023	SELL	$0.46 - $8.9 $2,668 - $51,620	-5,800 Reduced 4.84%	114,000 $54,000
Q3 2022 Nov 14, 2022	BUY	$0.08 - $22.6 $6,814 - $1.92 Million	85,175 Added 245.99%	119,800 $94,000
Q2 2022 Aug 10, 2022	BUY	$1.73 - $3.86 $3,589 - $8,009	2,075 Added 6.37%	34,625 $69,000
Q1 2022 May 09, 2022	BUY	$2.96 - $8.01 $96,348 - $260,725	32,550 New	32,550 $118,000

5.63M

Ticker JSPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,073,300
Market Cap $257M
Description
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...

Get notified when there are updates to the investment portfolio of Forefront Analytics, LLC, based on Form 13F filings with the SEC.

Stay updated on Forefront Analytics, LLC with notifications on news.